Cambridge Investment Research Advisors »

Athira Pharma shares owned by Cambridge Investment Research Advisors

Quarter-by-quarter ownership of Athira Pharma (ATHA) shares owned by Cambridge Investment Research Advisors from 13F filings

Historical chart of Cambridge Investment Research Advisors investment in Athira Pharma

Tip: Access up to 7 years of quarterly data

All positions including Athira Pharma held by Cambridge Investment Research Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Athira Pharma by Cambridge Investment Research Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $32k 12k 2.72

More positions owned by Cambridge Investment Research Advisors

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Apple Inc Com (AAPL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Core S&p500 Etf (IVV)
NVIDIA Corporation (NVDA)
Microsoft Corp Com (MSFT)
Vanguard Index Fds Total Stk Mkt (VTI)
Amazon Com Inc Com (AMZN)
Vanguard Star Fds Vg Tl Intl Stk F (VXUS)
SPDR S&p 500 Etf Tr Tr Unit (SPY)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Pacer Fds Tr Us Cash Cows 100 (COWZ)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Schwab Strategic Tr Us Dividend Eq (SCHD)
Vanguard Index Fds Value Etf (VTV)

View all positions for Cambridge Investment Research Advisors

Top funds holding Athira Pharma

Perceptive Advisors
Baker Bros. Advisors
Vanguard Group
Simplify Asset Management
Propel Bio Management
Tang Capital Management
BML Capital Management
Millennium Management
Pathstone Holdings
Citadel Advisors
Dimensional Fund Advisors
Two Sigma Investments
Two Sigma Advisers
Jacobs Levy Equity Management
GSA Capital Partners

View all funds holding Athira Pharma